Registry for lung transplant outcomes using the OCS Lung System

US National OCS Lung Thoracic Organ Perfusion (TOP) Registry

Observational TransMedics · NCT06513091

This study is tracking how well lung transplants work for patients who received donor lungs preserved with a new device called the OCS Lung System to see if it improves outcomes.

Quick facts

Study typeObservational
Enrollment10000 (estimated)
SexAll
SponsorTransMedics Industry-sponsored
Locations7 sites (Phoenix, Arizona and 6 other locations)
Trial IDNCT06513091 on ClinicalTrials.gov

What this trial studies

This registry aims to collect both short and long-term clinical outcome data from lung transplant recipients who have received donor lungs preserved and assessed using the OCS Lung System. The study will document the performance of the OCS device in real-world settings following its FDA approval in the United States. By gathering comprehensive data, the registry seeks to enhance understanding of lung transplant outcomes and the effectiveness of the OCS technology.

Who should consider this trial

Good fit: Ideal candidates for this registry are all individuals who have undergone lung transplantation.

Not a fit: Patients who have not received a lung transplant will not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could improve lung transplant outcomes and inform best practices for the use of the OCS Lung System.

How similar studies have performed: While this registry approach is not novel, it builds on previous successful registries that have documented transplant outcomes.

Eligibility criteria

Show full inclusion / exclusion criteria
All lung transplant recipients

Where this trial is running

Phoenix, Arizona and 6 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Lung Transplant
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.